Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes.

Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes. Am Heart J. 2004 Jan; 147(1):84-90.

View in: PubMed

subject areas

Aged
Angina, Unstable
Aspirin
Chi-Square Distribution
Double-Blind Method
Female
Heart Failure
Heparin
Humans
Male
Middle Aged
Myocardial Infarction
Odds Ratio
Peptides
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Regression Analysis
Syndrome
Treatment Outcome

authors with profiles

Robert Harrington